Lusefi 5mg Tab

Manufacturer
Taisho Pharmaceutical Co., Ltd.

Registraction Number     
MAL18091002AZ

 

Content

• Active Ingredient: Each tablet contains 5 mg of luseogliflozin hydrate, equivalent to 5 mg of luseogliflozin.
• Excipients: Includes lactose hydrate, microcrystalline cellulose, sodium starch glycolate, hydroxypropylcellulose, magnesium stearate, hypromellose, titanium oxide, macrogol 400, carnauba wax, and light anhydrous silicic acid.
• Appearance: White, film-coated tablet approximately 8.6 mm in diameter and 5.0 mm in thickness

Indications

• Monotherapy: For adults with type 2 diabetes mellitus whose blood glucose is inadequately controlled by diet and exercise alone, and for whom metformin is considered inappropriate due to intolerance.
• Add-on Combination Therapy: In combination with other glucose-lowering medications, including insulin preparations, in adult patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise plus monotherapy do not provide adequate control.

Instructions

• Dosage: Take 1 tablet (5 mg) once daily, either before or after breakfast.
• Administration: Swallow the tablet whole with a glass of water; do not chew, crush, or break it.
• Renal Impairment: Not recommended for use in patients with moderate to severe renal impairment (e.g., creatinine clearance <60 mL/min or estimated glomerular filtration rate <60 mL/min/1.73 m²).
• Monitoring: Regularly monitor plasma glucose, renal function, and other parameters during treatment.
• Missed Dose: If a dose is missed, take it as soon as possible unless it is almost time for the next dose. Do not take two doses at the same time to make up for a missed dose.